Evidence mapPaperPMID 42074491Full record

ArticleGenes2026

Association Between the

Petra Nussdorfer, Jernej Letonja, Matej Završnik, Boštjan Matos, Danijel Petrovič, Ines Cilenšek

Abstract read
In one paragraph

Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Petra NussdorferLaboratory for Histology and Genetics of Atherosclerosis and Microvascular Diseases, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.
Jernej LetonjaLaboratory for Histology and Genetics of Atherosclerosis and Microvascular Diseases, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.ORCID 0000-0002-1473-3534
Matej ZavršnikDepartment of Endocrinology and Diabetology, Internal Medicine Clinic, University Clinical Center, 2000 Maribor, Slovenia.
Boštjan MatosDepartment of Neurosurgery, University Clinical Center, 1000 Ljubljana, Slovenia.
Danijel PetrovičLaboratory for Histology and Genetics of Atherosclerosis and Microvascular Diseases, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.
Ines CilenšekLaboratory for Histology and Genetics of Atherosclerosis and Microvascular Diseases, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.

Funding

The Slovenian Research and Innovation Agency P3-0326
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiopoietin-2Diabetes Mellitus, Type 2Diabetic NephropathiesPolymorphism, Single NucleotideAgedAllelesCase-Control StudiesFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHumansMaleMiddle AgedSloveniaVascular Endothelial Growth Factor AAngiopoietin-2ANGPT2 protein, humanVascular Endothelial Growth Factor AVEGFA protein, humanANGPT2diabetic nephropathypolymorphismtype 2 diabetes mellitusVEGFA

Identifiers

PMID42074491
PMCPMC13116759

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.